XUND, a Vienna-based healthtech start-up that helps healthcare companies digitize the patient journey and translate data into valuable insights, announced that it closed €6 million in seed funding.
The round was led by global venture capital firms MMC Ventures and MassMutual Ventures and joined by RoX Health and LANA Ventures.
XUND will use the fresh capital to boost its growth, drive expansion beyond the DACH region and open up new markets in Europe. XUND plans to expand into the USA, with preparations for market entry by the Food and Drug Administration (FDA) already underway.
The recent funding will also enable the start-up to expand the product portfolio along the patient journey and integrate further promising use cases.
XUND has gained the trust of several renowned customers, including Wiener Städtische Versicherung and Generali, who, using XUND's technology, have built their digital ecosystem.
Tamás Petrovics, Co-Founder and CEO of XUND, on the financing round:
"We are overjoyed that we have been able to convince some of the most successful digital health and medtech investors from Europe and the USA to join us in our mission to build the data-driven healthcare system of tomorrow. The investment will make it possible for us to further refine the product-market fit, accelerate growth, and continue to improve our operations. Our goal is to cover the entire patient journey from prevention to diagnosis to treatment and monitoring, making XUND the central infrastructure provider for digital patient interactions in insurance, pharma, digital and personal healthcare."
Company: XUND Solutions GmbH
Raised: €6.0M
Round: Seed Round
Funding Month: September 2022
Lead Investors: MMC Ventures and MassMutual Ventures
Additional Investors: RoX Health and LANA Ventures
Company Website: https://xund.ai/
Software Category: Medical API
About the Company: Founded in 2018 by Lukas Seper, Tamás Petrovics, and Zoltán Tarabó in Vienna. XUND wants to revolutionize tomorrow's healthcare by providing patients and healthcare professionals with evidence-based solutions that support them in preventing and treating diseases. Using artificial intelligence, XUND can automatically analyze and process millions of medical publications to create the basis for its solutions. With their medical device, XUND enables healthcare companies to build a digital health assistant that helps customers, patients, and employees understand their symptoms, receive reliable assessments on what could be causing them, and take the right next steps.
Source: https://xund.ai/blog/xund-erhaelt-rekord-seed-investment-6-mio-euro-fuer-wiener-healthtech-start-up?destination=/press